AUROPHARMA - Swing Trade Analysis with AI Signals

Last Updated Time : 20 Dec 25, 07:00 am

Swing Trade Rating: 4.1

📊 AUROPHARMA shows good potential for swing trading. The stock is trading above both its 50 DMA (1,171 ₹) and 200 DMA (1,155 ₹), indicating strong technical support. Momentum indicators are favorable (RSI 56.3, MACD positive), suggesting bullish sentiment. The optimal entry price would be around 1,200–1,215 ₹ if the stock sustains above 1,200 ₹. If already holding, consider exiting near 1,340–1,360 ₹ (close to recent high resistance) or on weakness below 1,180 ₹.

✅ Positive

• 📈 Consistent quarterly profit growth (PAT up from 559 Cr. to 581 Cr., +8.16%).
• 💼 Strong trading volume (11.9 lakh vs avg 6.6 lakh), showing active participation.
• 📊 Stock trading above both 50 DMA and 200 DMA, confirming bullish trend.
• 📈 DII holdings increased (+0.67%), showing domestic institutional confidence.

⚠️ Limitation

• 📉 High valuation (P/E 35.2 vs Industry PE 30.6).
• 📉 Weak ROE (8.65%) and ROCE (10.8%).
• 📉 Low dividend yield (0.33%).
• 📉 PEG ratio of 8.25 indicates expensive growth expectations.

🚨 Company Negative News

• 📉 No major negative news reported, but FII holdings declined (-0.17%).

🌟 Company Positive News

• 📈 Stable quarterly profit growth and strong operational performance.
• 💼 Increased DII confidence with higher stake.

🏭 Industry

• 📊 Industry PE at 30.6, lower than AUROPHARMA’s P/E, suggesting slight overvaluation.
• 💊 Pharma sector remains defensive with steady demand, offering resilience in volatile markets.

📌 Conclusion

AUROPHARMA is a good candidate for swing trading with entry near 1,200–1,215 ₹ and exit near 1,340–1,360 ₹. Strong technicals and volume support the bullish outlook, though valuations are stretched. Traders should maintain a stop-loss below 1,180 ₹ to manage risk.

Would you like me to also prepare a side-by-side comparison of AUROPHARMA and ATUL so you can see which offers a stronger swing trade setup?